Tyce Gm
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
-
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 3
-
- Metabolism and Genetic Disorders 3
- Co-authors
- M D Muenter (7 shared papers)Donna L. Hammond (1 shared paper)Owen CA (4 shared papers)Shepherd Jt (1 shared paper)Vanhoutte Pm (1 shared paper)Fúster (1 shared paper)J A van Heerden (1 shared paper)Ernesto Solis (1 shared paper)
- Journals
- PubMed (17 papers)
- Partner nations
- United States
In The Last Decade
Tyce Gm
16 papers receiving 549 citations
Peers
Comparison fields: 5 of 65
- Neurology 410
- Cellular and Molecular Neuroscience 227
- Physiology 104
- Neurology 25
- Psychiatry and Mental health 36
Countries citing papers authored by Tyce Gm
This map shows the geographic impact of Tyce Gm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyce Gm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyce Gm more than expected).
Fields of papers citing papers by Tyce Gm
This network shows the impact of papers produced by Tyce Gm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyce Gm. The network helps show where Tyce Gm may publish in the future.
Co-authors
The 12 scholars most cited alongside Tyce Gm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. | 1971 | 223 |
| 2 | Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease. | 1977 | 138 |
| 3 | Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information. | 1981 | 79 |
| 4 | 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease. | 1973 | 27 |
| 5 | Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease. | 1972 | 20 |
| 6 | Acetylcholine--inhibition of transmitter release from adrenergic nerve terminals mediated by muscarinic receptors. | 1978 | 18 |
| 7 | Release of norepinephrine and serotonin in cat spinal cord: direct in vivo evidence for the activation of descending monoamine pathways by somatic stimulation. | 1981 | 18 |
| 8 | Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease. | 1989 | 17 |
| 9 | 3-O-Methyldopa in Parkinson's disease. | 1974 | 16 |
| 10 | Dihydroxyphenylalanine (DOPA) in plasma during dopa treatment of patients with Parkinson's disease. | 1970 | 15 |
| 11 | Dipyridamole levels in plasma of man and other species. | 1979 | 13 |
| 12 | Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease. | 1970 | 11 |
| 13 | High energy phosphates and catecholamine stores after prolonged ex vivo heart preservation. | 1987 | 5 |
| 14 | Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats. | 1989 | 2 |
| 15 | Demethylation of O-methyl metabolites of catecholamines in erythrocytes: a methanol-forming reaction. | 1977 | 1 |
| 16 | The carcinoid syndrome--a role for hemodialysis. | 1977 | 1 |
| 17 | Demethylation of 3-methoxy-4-hydroxyphenylalanine in the isolated perfused rat liver. | 1974 | 1 |
About Tyce Gm
Tyce Gm is a scholar working on Neurology, Clinical Biochemistry, Small Animals, Cellular and Molecular Neuroscience and Physiology, having authored 17 papers that have together received 605 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (3 papers), Metabolism and Genetic Disorders (3 papers), Diet and metabolism studies (2 papers), Veterinary Pharmacology and Anesthesia (2 papers), Receptor Mechanisms and Signaling (2 papers), Biochemical Analysis and Sensing Techniques (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Neurology (410 citations), Cellular and Molecular Neuroscience (227 citations), Physiology (104 citations), Neurology (25 citations) and Psychiatry and Mental health (36 citations). Tyce Gm has collaborated with scholars based in United States. Frequent co-authors include M D Muenter, Donna L. Hammond, Owen CA, Shepherd Jt, Vanhoutte Pm, Fúster, J A van Heerden, Ernesto Solis, Kaye Mp and Richard W. Bianco. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.